← Leaderboards
Paul Douglas Kennedy
Cayman Chemical Company, Inc.
$306,868
Attributed
$306,868
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$306,868 · 1
By mechanism
R43$306,868 · 1
Top collaborators
No co-investigators on record.
Most similar at Cayman Chemical Company, Inc.
Same institution · by research overlap
- Stephen Douglas Barrett$1,478,369
- Thomas A Owen$850,243
- Daniel Bochar$224,852
Others in their field
Other Rising Stars on “Alveolar Bone”
- Lu Huang · Univ Of Arkansas For Med Scis$1,941,372
- Daniel Puleston · Icahn School Of Medicine At Mount Sinai$1,507,564
- Sang Jin Lee · Wake Forest University Health Sciences$1,310,942
- Ranya Elsayed · Augusta University$1,089,935
- Mizuho Kittaka · Indiana University Indianapolis$1,019,929
- Fata Moradali · University Of Louisville$948,653
Research focus
Alveolar BoneAlveolar Bone LossAnabolic AgentsAnimal ModelAqueousArtificial Intelligence EnhancedBiochemicalBoneBone Formation StimulationBone GrowthBone HealingBone LossBone RegenerationBone RemodelingBone RepairBone ResorptionCaymansCell Culture TechniquesCellsCharacteristicsChromatinChronicClinical DevelopmentAging Population